Assessment of early paraprotein response to vincristine-doxorubicin-dexamethasone chemotherapy may help guide therapy in multiple myeloma.

v1

Type:Journal Article

0 views

[![NobleID](https://www.nobleid.org/api/badge/404AF7EE.svg?ark=w1%2F20260515%2F404AF7EE)](https://nobleid.org/work/w1/20260515/404AF7EE)

ARK Inflections

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors